GC Biopharma Corp. (KRX:006280)
South Korea flag South Korea · Delayed Price · Currency is KRW
124,900
-2,500 (-1.96%)
At close: Mar 28, 2025, 3:30 PM KST

GC Biopharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-26,280-26,63265,453123,21281,049
Upgrade
Depreciation & Amortization
81,03475,89965,09655,90448,791
Upgrade
Loss (Gain) From Sale of Assets
2,5112,919-40,657-6,991-59,361
Upgrade
Asset Writedown & Restructuring Costs
18,088---8,140
Upgrade
Loss (Gain) From Sale of Investments
-6,665-1,209660333-36,673
Upgrade
Loss (Gain) on Equity Investments
27,46438,43118,099-81,5335,635
Upgrade
Provision & Write-off of Bad Debts
1,0792,7892,2466,980336
Upgrade
Other Operating Activities
-6,5942,64917,11947,05269,970
Upgrade
Change in Accounts Receivable
52,815-47,09313,219-10,756-16,862
Upgrade
Change in Inventory
-229,626-69,2341,721-14,919-52,086
Upgrade
Change in Accounts Payable
12,07722,6894,011-16,463-3,906
Upgrade
Change in Other Net Operating Assets
20,637-6,681-27,81323,160-9,059
Upgrade
Operating Cash Flow
-53,460-5,473119,154125,97935,974
Upgrade
Operating Cash Flow Growth
---5.42%250.20%-10.72%
Upgrade
Capital Expenditures
-31,992-79,087-57,996-102,321-82,876
Upgrade
Sale of Property, Plant & Equipment
791.341,3191,540565.21236.6
Upgrade
Cash Acquisitions
---74,05311,918-1,582
Upgrade
Divestitures
215.13----
Upgrade
Sale (Purchase) of Intangibles
-9,602-45,914-36,694-21,143-18,345
Upgrade
Investment in Securities
-24,226-25,139-31,332-30,73424,393
Upgrade
Other Investing Activities
2,269-1,423-723.710,133107,856
Upgrade
Investing Cash Flow
-67,894-150,243-205,259-132,07729,684
Upgrade
Short-Term Debt Issued
1,221,1401,188,247806,151869,5001,044,670
Upgrade
Long-Term Debt Issued
279,3875,00030,608209,42923,800
Upgrade
Total Debt Issued
1,500,5271,193,247836,7591,078,9291,068,470
Upgrade
Short-Term Debt Repaid
-1,169,646-1,059,800-721,740-992,600-885,603
Upgrade
Long-Term Debt Repaid
-217,342-9,419-135,590-102,423-100,486
Upgrade
Total Debt Repaid
-1,386,988-1,069,219-857,330-1,095,023-986,088
Upgrade
Net Debt Issued (Repaid)
113,538124,028-20,571-16,09482,382
Upgrade
Dividends Paid
-19,532-24,825-23,985-18,511-12,719
Upgrade
Other Financing Activities
-160.891,30842,075-6,66511,325
Upgrade
Financing Cash Flow
93,845100,512-2,481-41,27080,987
Upgrade
Foreign Exchange Rate Adjustments
366.22-455.397,8911,141-12,818
Upgrade
Net Cash Flow
-27,143-55,660-80,694-46,228133,827
Upgrade
Free Cash Flow
-85,452-84,56061,15823,658-46,902
Upgrade
Free Cash Flow Growth
--158.51%--
Upgrade
Free Cash Flow Margin
-5.09%-5.20%3.57%1.54%-3.12%
Upgrade
Free Cash Flow Per Share
-7487.13-7408.975358.564681.52-4109.46
Upgrade
Cash Interest Paid
38,13924,08019,37813,5469,727
Upgrade
Cash Income Tax Paid
2,46819,03337,34918,8678,983
Upgrade
Levered Free Cash Flow
-119,077-166,64252,929-10,238-57,365
Upgrade
Unlevered Free Cash Flow
-93,803-148,84064,424-2,425-50,894
Upgrade
Change in Net Working Capital
153,267120,932-43,575-19,05729,830
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.